Remove Bioavailability Remove Drug Delivery Systems Remove Genome
article thumbnail

Skin Cancer Awareness Month 2024 and Insights from Medicus Pharma

XTalks

Advances in genomic sequencing and molecular diagnostics are helping healthcare providers to identify specific mutations and biomarkers associated with skin cancer. Dr. Bokhari: Medicus Pharma, through its subsidiary SkinJect, addresses these needs with its innovative transdermal drug delivery system (TDDS).

article thumbnail

Breaking the Waves: How Blue Ocean Strategy in Healthcare Can Propel Pharma / Biotech Companies to Success

Roots Analysis

Blue Ocean Strategy Example: Foundation Medicine has developed a genomic profiling test that helps oncologists identify the best treatment options for their patients based on their genetic makeup. Furthermore, new drug delivery methods can also help reduce healthcare costs by reducing the need for frequent doctor visits and hospitalizations.